Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sebocyte apoptosis induction refers to the process by which programmed cell death (apoptosis) is triggered in sebocytes, the specialized cells of sebaceous glands responsible for producing sebum. This mechanism is central to both physiological regulation of skin homeostasis and therapeutic interventions, particularly in conditions like acne vulgaris. Key molecules involved include isotretinoin, TRAIL, and NGAL, which activate caspase cascades and lead to cell death. The process is therapeutically relevant for treating conditions characterized by excessive sebum production.
Induction of programmed cell death in sebocytes, leading to reduced sebum production and sebaceous gland size.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sebocyte Apoptosis Induction.